☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
project orbis
AstraZeneca's Calquence (acalabrutinib) Receives the US FDA's Approval for Chronic Lymphocytic Leukemia Under the Project Orbis
November 22, 2019
PharmaShots Weekly Snapshot (September 16-20, 2019)
September 23, 2019
The US FDA Initiates its First Step Towards Project Orbis for Concurrent Review of Cancer Therapies
September 18, 2019
Merck's Keytruda (pembrolizumab) + Eisai's Lenvima (lenvatinib) Receives FDA's Approval for Certain Types of Endometrial Carcinoma
September 18, 2019
Load more...
Back to Home
